258 related articles for article (PubMed ID: 23812966)
1. Histone H1.0--a potential molecular marker with prognostic value for patients with malignant gliomas.
Gabrovsky N; Georgieva M; Laleva M; Uzunov K; Miloshev G
Acta Neurochir (Wien); 2013 Aug; 155(8):1437-42. PubMed ID: 23812966
[TBL] [Abstract][Full Text] [Related]
2. Stratifin expression is a novel prognostic factor in human gliomas.
Deng J; Gao G; Wang L; Wang T; Yu J; Zhao Z
Pathol Res Pract; 2011 Nov; 207(11):674-9. PubMed ID: 21940111
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-203 down-regulation is associated with unfavorable prognosis in human glioma.
He J; Deng Y; Yang G; Xie W
J Surg Oncol; 2013 Aug; 108(2):121-5. PubMed ID: 23813496
[TBL] [Abstract][Full Text] [Related]
4. Collaborative overexpression of matrix metalloproteinase-1 and vascular endothelial growth factor-C predicts adverse prognosis in patients with gliomas.
Xu Y; Zhong Z; Yuan J; Zhang Z; Wei Q; Song W; Chen H
Cancer Epidemiol; 2013 Oct; 37(5):697-702. PubMed ID: 23870768
[TBL] [Abstract][Full Text] [Related]
5. The impact of extent of resection and histological subtype on the outcome of adult patients with high-grade gliomas.
Yamaguchi S; Kobayashi H; Terasaka S; Ishii N; Ikeda J; Kanno H; Nishihara H; Tanaka S; Houkin K
Jpn J Clin Oncol; 2012 Apr; 42(4):270-7. PubMed ID: 22399670
[TBL] [Abstract][Full Text] [Related]
6. Up-regulation of microRNA-15b correlates with unfavorable prognosis and malignant progression of human glioma.
Pang C; Guan Y; Zhao K; Chen L; Bao Y; Cui R; Li G; Wang Y
Int J Clin Exp Pathol; 2015; 8(5):4943-52. PubMed ID: 26191187
[TBL] [Abstract][Full Text] [Related]
7. Survival following surgery and prognostic factors for recently diagnosed malignant glioma: data from the Glioma Outcomes Project.
Laws ER; Parney IF; Huang W; Anderson F; Morris AM; Asher A; Lillehei KO; Bernstein M; Brem H; Sloan A; Berger MS; Chang S;
J Neurosurg; 2003 Sep; 99(3):467-73. PubMed ID: 12959431
[TBL] [Abstract][Full Text] [Related]
8. Downregulation of chromatin remodeling factor CHD5 is associated with a poor prognosis in human glioma.
Wang L; He S; Tu Y; Ji P; Zong J; Zhang J; Feng F; Zhao J; Gao G; Zhang Y
J Clin Neurosci; 2013 Jul; 20(7):958-63. PubMed ID: 23707602
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of prognostic factors on survival in patients with low grade glioma.
Durmaz R; Vural M; Işildi E; Coşan E; Ozkara E; Bal C; Ciftçi E; Arslantaş A; Atasoy MA
Turk Neurosurg; 2008 Oct; 18(4):336-44. PubMed ID: 19107679
[TBL] [Abstract][Full Text] [Related]
10. Glycosphingolipid component profiles or human gliomas--correlation to survival time and histopathological malignancy grading.
Becker R; Rohlfs J; Jennemann R; Wiegandt H; Mennel HD; Bauer BL
Clin Neuropathol; 2000; 19(3):119-25. PubMed ID: 14606584
[TBL] [Abstract][Full Text] [Related]
11. Correlation of microRNA-375 downregulation with unfavorable clinical outcome of patients with glioma.
Chang C; Shi H; Wang C; Wang J; Geng N; Jiang X; Wang X
Neurosci Lett; 2012 Dec; 531(2):204-8. PubMed ID: 23103713
[TBL] [Abstract][Full Text] [Related]
12. A multivariate analysis of the prognostic factors of grade III gliomas.
Zhu YJ; Zhu XD; Wang SH; Shen F; Shen H; Liu WG
Chin Med J (Engl); 2008 Jun; 121(12):1072-5. PubMed ID: 18706219
[TBL] [Abstract][Full Text] [Related]
13. Longitudinal expression analysis of αv integrins in human gliomas reveals upregulation of integrin αvβ3 as a negative prognostic factor.
Schittenhelm J; Schwab EI; Sperveslage J; Tatagiba M; Meyermann R; Fend F; Goodman SL; Sipos B
J Neuropathol Exp Neurol; 2013 Mar; 72(3):194-210. PubMed ID: 23399898
[TBL] [Abstract][Full Text] [Related]
14. Expression of high-mobility group AT-hook protein 2 and its prognostic significance in malignant gliomas.
Liu B; Pang B; Hou X; Fan H; Liang N; Zheng S; Feng B; Liu W; Guo H; Xu S; Pang Q
Hum Pathol; 2014 Aug; 45(8):1752-8. PubMed ID: 24935062
[TBL] [Abstract][Full Text] [Related]
15. [Expression of Notch1, MMP-2 and MMP-9 and their significance in glioma patients].
Sun ZF; Wang L; Gu F; Fu L; Li WL; Ma YJ
Zhonghua Zhong Liu Za Zhi; 2012 Jan; 34(1):26-30. PubMed ID: 22490851
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-210 overexpression predicts poorer prognosis in glioma patients.
Lai NS; Dong QS; Ding H; Miao ZL; Lin YC
J Clin Neurosci; 2014 May; 21(5):755-60. PubMed ID: 24382515
[TBL] [Abstract][Full Text] [Related]
17. Extent of resection and survival in supratentorial infiltrative low-grade gliomas: analysis of and adjustment for treatment bias.
Gousias K; Schramm J; Simon M
Acta Neurochir (Wien); 2014 Feb; 156(2):327-37. PubMed ID: 24264163
[TBL] [Abstract][Full Text] [Related]
18. Over-expression of neuroepithelial-transforming protein 1 confers poor prognosis of patients with gliomas.
Tu Y; Lu J; Fu J; Cao Y; Fu G; Kang R; Tian X; Wang B
Jpn J Clin Oncol; 2010 May; 40(5):388-94. PubMed ID: 20304779
[TBL] [Abstract][Full Text] [Related]
19. Resection, biopsy, and survival in malignant glial neoplasms. A retrospective study of clinical parameters, therapy, and outcome.
Devaux BC; O'Fallon JR; Kelly PJ
J Neurosurg; 1993 May; 78(5):767-75. PubMed ID: 8468607
[TBL] [Abstract][Full Text] [Related]
20. [Prognostic value of epileptic seizures in patients with cerebral gliomas].
Krzyszkowski T; Czepko R; Betlej M
Ann Acad Med Stetin; 2004; 50(1):35-40. PubMed ID: 16871742
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]